A comprehensive view of Infections & Infectious Diseases. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

HHS ships monkeypox tests to five commercial laboratories to expand nation’s testing capacity, make tests more convenient, with testing ramping up through July; tests sent to Sonic Healthcare, Aegis Science, Labcorp, Mayo Clinic, Quest Diagnostics

Fitch: Covid-19 vaccine sales saw strong start to 2022, with Pfizer and Moderna posting stronger-than-expected Q1 sales; 2022 sales could be comparable to significant 2021 numbers, but estimates for 2023 should see more pronounced decrease in market size

FDA approves Merck’s Vaxneuvance pneumococcal 15-valent conjugate vaccine for children ages 6 weeks to 17 years old; vaccine administered in four-dose series, provides superior immune response against pneumococcal serotype 3, unique serotypes 22F, 33F

Merck reports experimental injectable pneumococcal vaccine V116 met primary immunogenicity objectives in Phase 1-2 study; vaccine targets 21 strains of Streptococcus pneumoniae that cause 85% of pneumonia cases in adults 65 years and over in US

Pfizer investing US$95M in vaccine company Valneva SE; investment supports strategic partnership between both companies to develop Lyme disease vaccine

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count